Is VISAX or JNJ a better dividend investment in 2026?

VISAX currently yields 3.53% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: VISAX offers higher current income.

What is the dividend yield difference between VISAX and JNJ?

VISAX has a forward dividend yield of 3.53% ($0.67/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 0.17 percentage points.

Home › Compare › VISAX vs JNJ

VISAX vs JNJ: Dividend Comparison 2026

VISAX yields 3.53% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VISAX wins by $5.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

VISAX

● Live price

3.53%

Share price

$19.12

Annual div

$0.67

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.1K

Annual income

$442.32

Full VISAX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — VISAX vs JNJ

📍 VISAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VISAX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VISAX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VISAX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VISAX

Annual income on $10K today (after 15% tax)

$299.70/yr

After 10yr DRIP, annual income (after tax)

$375.97/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $327.64/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VISAX + JNJ for your $10,000?

VISAX: 50%JNJ: 50%

100% JNJ50/50100% VISAX

Portfolio after 10yr

$22.6K

Annual income

$635.05/yr

Blended yield

2.81%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VISAX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VISAX buys

JNJ buys

No recent congressional trades found for VISAX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVISAXJNJ

Forward yield	3.53% ✓	3.36%
Annual dividend / share	$0.67	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$25.1K ✓	$20.0K
Annual income after 10y	$442.32	$827.78 ✓
Total dividends collected	$4.0K	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: VISAX vs JNJ ($10,000, DRIP)

Year	VISAX Portfolio	VISAX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,053	$352.58	$10,676	$355.77	+$377.00 → VISAX
2	$12,190	$364.20	$11,407	$389.39	+$783.00 → VISAX
3	$13,419	$375.42	$12,198	$426.53	+$1.2K → VISAX
4	$14,745	$386.22	$13,056	$467.62	+$1.7K → VISAX
5	$16,174	$396.61	$13,987	$513.12	+$2.2K → VISAX
6	$17,712	$406.58	$14,998	$563.56	+$2.7K → VISAX
7	$19,368	$416.13	$16,098	$619.52	+$3.3K → VISAX
8	$21,149	$425.27	$17,295	$681.69	+$3.9K → VISAX
9	$23,064	$434.00	$18,599	$750.82	+$4.5K → VISAX
10	$25,121	$442.32	$20,022	$827.78	+$5.1K → VISAX

VISAX vs JNJ: Complete Analysis 2026

VISAX — Stock

The investment seeks capital appreciation. Under normal circumstances, the fund invests at least 80% of its assets in equity securities of non-U.S. small- and mid-capitalization companies. The advisor intends to diversify its investments among countries and normally to have represented in the portfolio business activities of a number of different countries. Equity securities in which the fund invests include common stocks, preferred stocks and American Depositary Receipts (ADRs). It is non-diversified.

Full VISAX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this VISAX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VISAX vs SCHD VISAX vs JEPI VISAX vs O VISAX vs KO VISAX vs MAIN VISAX vs ABBV VISAX vs MRK VISAX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.